Der er også beskrevet en øget forekomst af myopati hos patienter, der behandles med andre statiner i kombination med hæmmere af cytokrom P450 metabolismen.
An increase in the incidence of myopathy has also been described in patients receiving other statins in combination with inhibitors of cytochrome P450 metabolism.